Matches in Nanopublications for { ?s ?p "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP403258.RAQTLjWY3FIA_C7vKR6z--agX7wVJfs60aHljxoEYoKn8130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403258.RAQTLjWY3FIA_C7vKR6z--agX7wVJfs60aHljxoEYoKn8130_provenance.
- NP403204.RAo_LJZNpon6xmnm7DirrYyerFXIrrZEI1vqhtiTXMYlA130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403204.RAo_LJZNpon6xmnm7DirrYyerFXIrrZEI1vqhtiTXMYlA130_provenance.
- NP968360.RApN3bJ8K_rxQ-lD-3tLRt3YztGKN-5-kocM6urhXraQM130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968360.RApN3bJ8K_rxQ-lD-3tLRt3YztGKN-5-kocM6urhXraQM130_provenance.
- NP968362.RALrHkzHgTJhDHyM06QXSZSKK5IBnpLURg_fhM7RAP-6E130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968362.RALrHkzHgTJhDHyM06QXSZSKK5IBnpLURg_fhM7RAP-6E130_provenance.
- NP955640.RAyLWI-zc0d4C7tvgcrcMeA6NkcA1uls-JeTcN4EBTPMM130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955640.RAyLWI-zc0d4C7tvgcrcMeA6NkcA1uls-JeTcN4EBTPMM130_provenance.
- NP955659.RA8O-UbE_4jr5lVYznzHpdIKYSvaO8VgRqLnxvHFrTikg130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955659.RA8O-UbE_4jr5lVYznzHpdIKYSvaO8VgRqLnxvHFrTikg130_provenance.
- NP968354.RA19S-wypNJYhH_mZfXl5a85mF9XUd1PNnpn4sfEIUkJw130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968354.RA19S-wypNJYhH_mZfXl5a85mF9XUd1PNnpn4sfEIUkJw130_provenance.
- NP968358.RA_0FocgvRAJMz06_Z2MFp4433RIVDKEmNTtpd0wzQOwc130_assertion description "[Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968358.RA_0FocgvRAJMz06_Z2MFp4433RIVDKEmNTtpd0wzQOwc130_provenance.